Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.48 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.48 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.42 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29831656 | 1.00 | SHBG (0.48) | SHBGESR1ESR2HMGB1CXCL12 | |
| SCHEMBL17095067 | 0.95 | SHBG (0.44) | SHBGESR1ESR2HMGB1CXCL12 | |
| SCHEMBL218662 | 0.92 | SHBG (0.55) | SHBGESR1ESR2HMGB1CXCL12 | |
| SCHEMBL21839318 | 0.90 | ESR1 (0.49) | SHBGESR1ESR2HMGB1CXCL12 | |
| SCHEMBL7757417 | 0.89 | AMY1A (0.54) | SHBGESR1ESR2HMGB1CXCL12 | |
| SCHEMBL4055787 | 0.87 | SHBG (0.47) | SHBGESR1ESR2HMGB1CXCL12 | |
| SCHEMBL278275 | 0.82 | MAPT (0.45) | — | |
| SCHEMBL14462649 | 0.80 | ESR1 (0.63) | SHBGESR1ESR2HMGB1CXCL12 | |
| Pyrogallol SCHEMBL17453322 | 0.80 | TRPA1 (0.48) | SHBGESR1ESR2HMGB1CXCL12 | |
| SCHEMBL7776274 | 0.80 | CYP2C9 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 264 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9939747-B2 | Developing agent and method for producing the same | TOSHIBA TEC KABUSHIKI KAISHA (JP) | 2018-04-10 | — | — | US | claimed |
| US-20170038698-A1 | DEVELOPING AGENT AND METHOD FOR PRODUCING THE SAME | TOSHIBA TEC KABUSHIKI KAISHA (JP) | 2017-02-09 | — | — | US | claimed |
| EP-1902852-A1 | Erasable image forming material | Kabushiki Kaisha Toshiba (JP) | 2008-03-26 | — | — | EP | claimed |
| US-20080070781-A1 | Erasable image forming material | KABUSHIKI KAISHA TOSHIBA | 2008-03-20 | — | — | US | claimed |
| US-7302846-B2 | Temperature-sensing device for determining the level of a fluid | HADALA ANTHONY J | 2007-12-04 | — | — | US | claimed |
| EP-1623274-A2 | PHOTORESIST COMPOSITIONS | AZ Electronic Materials USA Corp. (US) | 2006-02-08 | — | — | EP | claimed |
| US-20050199057-A1 | Temperature-sensing device for determining the level of a fluid | HADALA ANTHONY J (US) | 2005-09-15 | — | — | US | claimed |
| WO-2004088423-A2 | PHOTORESIST COMPOSITIONS | AZ ELECTRONIC MATERIALS USA CORP. (US) | 2004-10-14 | — | — | WO | claimed |
| US-20040197704-A1 | Photoresist compositions | AZ ELECTRONIC MATERIALS USA CORP. | 2004-10-07 | — | — | US | claimed |
| US-6790582-B1 | NOVOLAK RESIN PARTIALLY ESTERIFIED WITH NAPHTHOQUINONEDIAZIDOSULFONYL GROUP; DILUTION RESIN(S), AND SOLVENT | CLARIANT FINANCE BVI LIMITED (VG) | 2004-09-14 | — | — | US | claimed |
| CN-113646052-B | Reversible thermochromic composition, reversible thermochromic microcapsule pigment, and writing instrument | 百乐墨水株式会社 | 2024-05-17 | — | — | CN | disclosed |
| US-11768434-B2 | Polymer having a structure of polyamide, polyamide-imide, or polyimide, photosensitive resin composition, patterning process, photosensitive dry film, and protective film for electric and electronic parts | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-09-26 | — | — | US | disclosed |
| US-11768434-B2 | Polymer having a structure of polyamide, polyamide-imide, or polyimide, photosensitive resin composition, patterning process, photosensitive dry film, and protective film for electric and electronic parts | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-09-26 | — | — | US | disclosed |
| CN-113785023-B | Water-based ink composition for reversible thermochromic writing instrument, refill for refill and water-based ballpoint pen incorporating same | 株式会社百乐 | 2023-05-12 | — | — | CN | disclosed |
| US-11572442-B2 | Compound, polyimide resin and method of producing the same, photosensitive resin composition, patterning method and method of forming cured film, interlayer insulating film, surface protective film, and electronic component | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2023-02-07 | — | — | US | disclosed |
| EP-0980028-A1 | Erasable image forming material | KABUSHIKI KAISHA TOSHIBA (JP) | 2000-02-16 | — | — | EP | disclosed |
| EP-0943640-A1 | HIGHLY HEAT-RESISTANT, HIGH-PURITY POLYARYLATE AND FILM PRODUCED FROM THE SAME | UNITIKA LTD. (JP) | 1999-09-22 | — | — | EP | disclosed |
| EP-0477691-B1 | Positive-type photoresist composition | FUJI PHOTO FILM CO LTD (JP) | 1997-07-16 | — | — | EP | disclosed |
| US-5340686-A | Alkali soluble phenol novolak resin, 1,2-quinone diazide compound and low molecular weight novolak compound | FUJI PHOTO FILM CO., LTD. (JP) | 1994-08-23 | — | — | US | disclosed |
| EP-0477691-A2 | Positive-type photoresist composition | FUJI PHOTO FILM CO., LTD. (JP) | 1992-04-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11572442-B2 | Compound, polyimide resin and method of producing the same, photosensitive resin composition, patterning method and method of forming cured film, interlayer insulating film, surface protective film, and electronic component | BRIX1, RBX1, HAX1 | SHBG 2374/4885ESR1 54/4885ESR2 138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.